Откуда берутся дети? Краткий путеводитель по переходу из лагеря чайлдфри к тихим радостям семейственности — страница 53 из 58

221 (S1), jeb164517.

9. Millership, S. J. et al. (2019). Genomic imprinting and its effects on postnatal growth and adult metabolism. Cellular and Molecular Life Sciences, 76, 4009–4021.

10. Dini, P. et al. (2021). Parental bias in expression and interaction of genes in the equine placenta. PNAS, 118 (16), e2006474118.

11. Imakawa, K. et al. (2022). Endogenous retroviruses and placental evolution, development, and diversity. Cells, 11, 2458.

12. Jaremek, A. et al. (2021). Omics approaches to study formation and function of human placental syncytiotrophoblast. Frontiers in Cell and Developmental Biology, 9, 674162.

13. Perez-Munoz, M. E. et al. (2017). A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome. Microbiome, 5, 48.

14. Denner, J. (2016). Expression and function of endogenous retroviruses in the placenta. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 124 (1–2), 31–43.

15. Meyer, T. J. et al. (2017). Endogenous retroviruses: with us and against us. Frontiers in Chemistry, 5, 23.

16. Tong, M. & Abrahams, V. M. (2020). Immunology of the placenta. Obstetrics and Gynecology Clinics of North America, 47 (1), 49–63.

17. Mor, G. & Cardenas, I. (2010). The immune system in pregnancy: a unique complexity. American Journal of Reproductive Immunology, 63 (6), 425–433.

18. Piccinni, M. et al. (2016). How pregnancy can affect autoimmune diseases progression? Clinical and Molecular Allergy, 14, 11.

19. Sappenfield, E. et al. (2013). Pregnancy and susceptibility to infectious diseases. Infectious Diseases in Obstetrics and Gynecology, 2013, 752852.

20. Kay, A. W. & Blish, C. A. (2015). Immunogenicity and clinical efficacy of influenza vaccination in pregnancy. Frontiers in Immunology, 6, 289.

21. Jamieson, D. J. & Rasmussen, S. A. (2022). An update on COVID-19 and pregnancy. American Journal of Obstetrics and Gynecology, 226 (2), 177–186.

22. Cole, L. A. (2012). hCG, the wonder of today’s science. Reproductive Biology and endocrinology, 10, 24.

23. Nwabuobi, C. et al. (2017). hCG: biological functions and clinical applications. International Journal of Molecular Sciences, 18, 2037.

24. Tal, R. & Taylor, H. S. Endocrinology of Pregnancy. [Updated 2021 Mar 18]. In: Feingold, K. R., Anawalt, B., Blackman, M. R., et al., editors. Endotext [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK278962/

25. Talbot, L. & Maclennan, K. (2016). Physiology of pregnancy. Anaesthesia & Intensive Care Medicine, 17 (7), 341–345.

26. Costantine, M. (2014). Physiologic and pharmacokinetic changes in pregnancy. Frontiers in Pharmacology, 5, 65.

27. Rassie, K. et al. (2022). Human placental lactogen in relation to maternal metabolic health and fetal outcomes: a systematic review and meta-analysis. International Journal of Molecular Sciences, 23, 15621.

28. Velegrakis, A. et al. (2017). Human placental growth hormone in normal and abnormal fetal growth (review). Biomedical Reports, 7, 115–122.

29. Brunton, P. J. & Russell, J. A. (2010). Endocrine induced changes in brain function during pregnancy. Brain Research, 1364, 198–215.

30. Brown, E. & Schaffir, J. (2019). “Pregnancy brain”: a review of cognitive changes in pregnancy and postpartum. Obstetrical & Gynecological Survey, 74 (3), 178–185.

31. Saltzman, W. & Maestripieri, D. (2012). The neuroendocrinology of primate maternal behavior. Progress in Neuropharmacology and Biological Psychiatry, 35 (5), 1192–1204.

32. McEvoy, K. & Osborne, L. M. (2019). Allopregnanolone and reproductive psychiatry: an overview. International Review of Psychiatry, 31 (3), 237–244.

33. Sundstrom-Poromaa, I. et al. (2020). Progesterone – friend or foe? Frontiers in Neuroendocrinology, 59, 100856.

34. Azhar, Y., Din, A. U. Brexanolone. [Updated 2022 Jun 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK541054/

35. Martinez-Garcia, M. et al (2021). Characterizing the brain structural adaptations across the motherhood transition. Frontiers in Global Women’s Health, 2, 742775.

36. Martinez-Garcia, M. et al (2021). Do pregnancy-induced brain changes reverse? The brain of a mother six years after parturition. Brain Sciences, 11, 168.

37. Aleknaviciute, J. et al (2022). Long-term association of pregnancy and maternal brain structure: the Rotterdam Study. European Journal of Epidemiology, 37, 271–281.

38. Судебная медицина: учебник / под общ. ред. В. Н. Крюкова. 2-е изд., перераб. и доп. М.: Норма, 2009.

39. Ubelaker, D. H. & De La Paz, J. S. (2012). Skeletal indicators of pregnancy and parturition: a historical review. Journal of Forensic Sciences, 57 (4), 866–872.

40. Waltenberger, L. et al. (2022). Are parturition scars truly signs of birth? The estimation of parity in a well-documented modern sample. International Journal of Osteoarchaeology, 32 (3), 619–629.

41. Rosner, M. et al. (2021). Fetomaternal microchimerism and genetic diagnosis: on the origins of fetal cells and cell-free fetal DNA in the pregnant woman. Mutation Research. Reviews in Mutation Research, 788, 108399.

42. Bianchi, D. W. et al. (2021). Forever connected: the lifelong biological consequences of fetomaternal and maternofetal microchimerism. Clinical Chemistry, 67 (2), 351–362.

43. Comitre-Mariano, B. et al. (2021). Feto-maternal microchimerism: memories from pregnancy. iScience, 25 (1), 103664.

44. Breveglieri, G. et al. (2019). Non-invasive prenatal testing using fetal DNA. Molecular Diagnosis & Therapy, 23 (2), 291–299.

45. Paul, L. T. & Ergoren, M. C. (2022). Comparison of bioinformatics approaches for fetal microdeletions and monogenic variations estimation in non-invasive prenatal testing. Global Medical Genetics, 9 (2), 72–75.

Глава 5. Не только запреты, но и привилегии

1. Oladipupo, I. et al. (2022). Association between cigarette smoking and ovarian reserve among women seeking fertility care. PLoS ONE, 17 (12), e0278998.

2. Vanegas, J. C. et al. (2017). Discrete survival model analysis of a couple’s smoking pattern and outcomes of assisted reproduction. Fertility Research and Practice, 3, 5.

3. Meeker, J. D. & Benedict, M. D. (2013). Infertility, pregnancy loss and adverse birth outcomes in relation to maternal secondhand tobacco smoke exposure. Current Women’s Health Reviews, 9 (1), 41–49.

4. Ekblad, M. et al. (2015). Smoking during pregnancy affects foetal brain development. Acta Paediatrica, 104, 12–18.

5. United States Public Health Service Office of the Surgeon General; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Smoking Cessation: A Report of the Surgeon General [Internet]. Washington (DC): US Department of Health and Human Services; 2020. Chapter 4, The Health Benefits of Smoking Cessation. https://www.ncbi.nlm.nih.gov/books/NBK555590/

6. Sailer, S. et al (2019). Impact of nicotine replacement and electronic Rnicotine delivery systems on fetal brain development. International Journal of Environmental Research and Public Health, 16, 5113.

7. Moon, R. Y. et al. (2022). Sleep-related infant deaths: updated 2022 recommendations for reducing infant deaths in the sleep environment. Pediatrics, 150 (1), e2022057990.

8. Liu, B. et al. (2020). Maternal cigarette smoking before and during pregnancy and the risk of preterm birth: a dose-response analysis of 25 million mother-infant pairs. PLOS Medicine, 17 (8), e10031158.

9. Anderson, T. M. et al. (2019). Maternal smoking before and during pregnancy and the risk of sudden unexpected infant death. Pediatrics, 143 (4), e20183325.

10. Leite, M. et al. (2014). Maternal smoking in pregnancy and risk for congenital malformations: results of a Danish register-based cohort study. Acta Obstetricia et Gynecologica Scandinavica, 93 (8), 825–834.

11. Raisanen, S. et al. (2014). Smoking cessation in the first trimester reduces most obstetric risks, but not the risks of major congenital anomalies and admission to neonatal care: a population-based cohort study of 1 164 953 singleton pregnancies in Finland. Journal of epidemiology and community health, 68 (2), 159–164.

12. Adam, M. P. (2012). The all-or-none phenomenon revisited. Birth Defects Research. Part A, Clinical and Molecular Teratology, 94 (8), 664–669.

13. Gilbert-Barness, E. (2010). Review: teratogenic causes of malformations. Annals of Clinical & Laboratory Science, 40 (2), 99–114.

14. Legault, L. M. et al. (2021). Pre-implantation alcohol exposure induces lasting sex-specific DNA methylation programming errors in the developing forebrain. Clinical Epigenetics, 13, 164.

15. Nykjaer, C. et al. (2014). Maternal alcohol intake prior to and during pregnancy and risk of adverse birth outcomes: evidence from a British cohort. Journal of epidemiology and community health, 68 (6), 542–549.

16. Zhou, Q. et al. (2020). Association between preconception paternal smoking and birth defects in offspring: evidence from the database of the National Free Preconception Health Examination Project in China. An International Journal of Obstetrics and Gynaecology, 127 (11), 1358–1364.

17. Wilhoit, L. F. et al. (2017). Fetal alcohol spectrum disorders: characteristics, complications, and treatment.